Leading Pediatric Osteosarcoma Nonprofit to Present $700,000 to 10 Scientists During Annual Conference to Find Kinder Treatments for Patients

Strategic Insights -

Since its inception in 2016, MIB Agents, a leading pediatric osteosarcoma nonprofit, has awarded $2.5 million to scientists across the country through its grant program. The OutSmarting Osteosarcoma grants are supported by MIB Agents Family Funds, osteosarcoma patients and families who raise research dollars in honor of an OsteoWarrior or an OsteoAngel. This year, the nonprofit will award $700,000 in grants to 10 scientists dedicated to moving osteosarcoma cancer research forward. Osteosarcoma is an aggressive, malignant, primary bone cancer affecting 800-900 people in the U.S. each year and is the most common bone cancer affecting children and young adults.

Key Takeaways:

  • MIB Agents, a pediatric osteosarcoma nonprofit, has awarded $2.5 million to scientists across the country through its grant program since 2016.
  • The OutSmarting Osteosarcoma grants are supported by MIB Agents Family Funds, osteosarcoma patients and families who raise research dollars in honor of an OsteoWarrior or an OsteoAngel.
  • Ten scientists will receive $700,000 in grants to 10 scientists dedicated to moving osteosarcoma cancer research forward during the MIB Agents Annual Conference.
  • Osteosarcoma is an aggressive, malignant, primary bone cancer affecting 800-900 people in the U.S. each year and is the most common bone cancer affecting children and young adults.
  • The OutSmarting Osteosarcoma 2025 grant recipients receiving $100,000 Hero grants include Alexander Davies, Amy LeBlanc, Corey Weistuch, and David Ulmert, among others.
  • With the help of MIB Agents' grant program, scientists and researchers hope to find kinder treatments for patients with osteosarcoma.
  • Dr. David Ulmert, one of the recipients, stated, "This award isn't just support for our research—it's a lifeline of hope, a reminder that we are not alone in this fight to spare others from the heartbreak of this disease."
  • MIB Agents' grant program represents a partnership between the scientific and patient community with patients and their families funding much-needed research.
  • The nonprofit announced an additional $700,000 in grants, raising the total to $2.9 million, in addition to the $500,000 previously awarded in 2025.

Statistics:

  • $2.5 million: total amount awarded by MIB Agents to scientists across the country through its grant program since 2016.
  • $700,000: amount awarded to 10 scientists during the MIB Agents Annual Conference.
  • 800-900: number of people affected by osteosarcoma in the U.S. each year.
  • 2016: year MIB Agents was founded.
  • 2012: year MIB Agents was founded as stated in the source material.

Sources:

  • MIB Agents (Founded in 2012)
  • OutSmarting Osteosarcoma grant program
  • MIB Agents' grant recipients include David Ulmert, MD, PhD, at UCLA, Alexander Davies, DVM, PhD, at Oregon Health & Science University, Amy LeBlanc, DVM, at National Cancer Institute, and others.